Clinical trial
A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung…
NCT00403403 · Genentech, Inc., Industry · Completed
Key facts
| NCT number | NCT00403403 |
|---|---|
| Title | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) |
| Official title | A Placebo-Controlled, Double-Blind, Multicenter, Randomized, Phase II Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer |
| Lead sponsor | Genentech, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Bevacizumab, Chemotherapy, Placebo |
| Enrollment | 102 |
| Start date | Mar 1, 2007 |
| Primary completion | Feb 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Nov 23, 2006 |
| Last update posted | Apr 29, 2011 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: